REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Affidea Onkoterapia Sp. z o.o. (Poland)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Administrative Management and General Management Consulting Services | Marketing Research and Public Opinion Polling | All Other Miscellaneous Schools and Instruction | Ambulatory Health Care Services | All Other Miscellaneous Ambulatory Health Care Services | Electronic and Precision Equipment Repair and Maintenance | Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Full name: Affidea Onkoterapia Sp. z o.o. Profile Updated: June 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Affidea Onkoterapia Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. The enterprise operates in the General Medical and Surgical Hospitals industry. It was incorporated on December 14, 2006. It currently has a total number of 99 (2020) employees. From the latest financial highlights, Affidea Onkoterapia Sp. z o.o. reported a net sales revenue increase of 4.27% in 2022. Its total assets decreased by 19.78% over the same period. Affidea Onkoterapia Sp. z o.o.’s net profit margin decreased by 7.98% in 2022.

Headquarters
Ul. Plac Europejski 2
Warsaw; Mazowieckie; Postal Code: 00-844

Contact Details: Purchase the Affidea Onkoterapia Sp. z o.o. report to view the information.

Website: http://www.affidea.pl

Basic Information
Total Employees:
Purchase the Affidea Onkoterapia Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Affidea Onkoterapia Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Affidea Onkoterapia Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Affidea Onkoterapia Sp. z o.o. report to view the information.
Incorporation Date:
December 14, 2006
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Nu - Med Grupa S.A.
100%
European Medical Partner Sp. z o.o.
71%
Company Performance
Financial values in the chart are available after Affidea Onkoterapia Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
4.27%▲
Total operating revenue
5.52%▲
Operating profit (EBIT)
-18.89%▼
EBITDA
-22.47%▼
Net Profit (Loss) for the Period
-44.46%▼
Total assets
-19.78%▼
Total equity
24.03%▲
Operating Profit Margin (ROS)
-5.09%▼
Net Profit Margin
-7.98%▼
Return on Equity (ROE)
11.64%▲
Debt to Equity Ratio
-4.58%▼
Quick Ratio
0.95%▲
Cash Ratio
1.25%▲

Similar companies

Tc-Med Sp. z o.o.
 
Uniwersyteckie Centrum Kliniczne
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie
 
Szpitale Pomorskie Sp. z o.o.
Copernicus Podmiot Leczniczy Sp. z o.o.
 
Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza-Radeckiego We Wroclawiu
Powiatowe Centrum Zdrowia Sp. z o.o.
 
1 Wojskowy Szpital Kliniczny Z Poliklinika Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Lublinie
Krapkowickie Centrum Zdrowia Sp. z o.o.
 
"Centrum Sluchu I Mowy" - Sp. z o.o.
Samodzielny Publiczny Zespol Zakladow Opieki Zdrowotnej W Przasnyszu
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo